{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:44:06Z","timestamp":1792122246954,"version":"4.4.0"},"reference-count":60,"publisher":"Informa UK Limited","issue":"13","funder":[{"name":"National Cancer Institute","award":["P30 CA240139"],"award-info":[{"award-number":["P30 CA240139"]}]},{"name":"Riney Family Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100013352","name":"Tow Foundation","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100013352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2022,11,10]]},"DOI":"10.1080\/10428194.2022.2113532","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T07:17:01Z","timestamp":1662362221000},"page":"3032-3043","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscape"],"prefix":"10.1080","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-0917","authenticated-orcid":false,"given":"Dickran","family":"Kazandjian","sequence":"first","affiliation":[{"name":"Myeloma Division, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Myeloma Division, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-4839","authenticated-orcid":false,"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"name":"Myeloma Division, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.10.008"},{"key":"CIT0002","unstructured":"2021 1\/25\/2022. FDA approves first cell-based gene therapy for adult patients with multiple myeloma. In FDA news release. Food and drug administration. [cited 2022 Jan 25]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cell-based-gene-therapy-adult-patients-multiple-myeloma."},{"key":"CIT0003","unstructured":"2022 4\/8\/2022. FDA approves ciltacabtagene autoleucel for relapsed or refractory multiple myeloma. [cited 2022 Apr 8]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-ciltacabtagene-autoleucel-relapsed-or-refractory-multiple-myeloma."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02551"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S288840"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.02.004"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900496"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1268307"},{"key":"CIT0009","first-page":"38","volume":"8","author":"Liu H","year":"2017","journal-title":"Front Immunol"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26379"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.10.478"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0356-3"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32909"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02657"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0734-z"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09241.x"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-691162"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02657"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134063"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.8006"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-150519"},{"key":"CIT0024","unstructured":"2021 1\/25\/2022. Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma. Pfizer; 2022."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01338-6"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147915"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148723"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139192"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-144921"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139893"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-150757"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-122895"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-1216"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146868"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153817"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148813"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1551676"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0178-8"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147983"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01187"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS3132"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2752"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000110"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148176"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152160"},{"key":"CIT0046","unstructured":"1\/25\/22. anti-CD38\/CD28xCD3 trispecific T cell engager SAR442257. National Cancer Institute. [cited 2022 Jan 25]. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/anti-cd38-cd28xcd3-tri-specific-monoclonal-antibody-sar442257."},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2017.6"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147418"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.8045"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1616506"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118970"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01602-0"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014611"},{"key":"CIT0054","unstructured":"Liu A. Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supply; 2021. [2022 Mar 31]. Available from: https:\/\/www.fiercepharma.com\/manufacturing\/bristol-myers-hits-car-t-manufacturing-bottleneck-as-abecma-demand-outstrips-supply."},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00466-6"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0611"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01935"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16764"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.09.015"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2022.2113532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T04:03:37Z","timestamp":1671336217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2022.2113532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":60,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,11,10]]}},"alternative-id":["10.1080\/10428194.2022.2113532"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2022.2113532","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}